当前位置: 首页 >> 检索结果
共有 31424 条符合本次的查询结果, 用时 2.8346222 秒

1301. Efficacy of commercial weight-loss programs: an updated systematic review.

作者: Kimberly A Gudzune.;Ruchi S Doshi.;Ambereen K Mehta.;Zoobia W Chaudhry.;David K Jacobs.;Rachit M Vakil.;Clare J Lee.;Sara N Bleich.;Jeanne M Clark.
来源: Ann Intern Med. 2015年162卷7期501-12页
Commercial and proprietary weight-loss programs are popular obesity treatment options, but their efficacy is unclear.

1302. The optimal imaging strategy for patients with stable chest pain: a cost-effectiveness analysis.

作者: Tessa S S Genders.;Steffen E Petersen.;Francesca Pugliese.;Amardeep G Dastidar.;Kirsten E Fleischmann.;Koen Nieman.;M G Myriam Hunink.
来源: Ann Intern Med. 2015年162卷7期474-84页
The optimal imaging strategy for patients with stable chest pain is uncertain.

1303. Surgery versus nonsurgical treatment of lumbar spinal stenosis: a randomized trial.

作者: Anthony Delitto.;Sara R Piva.;Charity G Moore.;Julie M Fritz.;Stephen R Wisniewski.;Deborah A Josbeno.;Mark Fye.;William C Welch.
来源: Ann Intern Med. 2015年162卷7期465-73页
Primary care management decisions for patients with symptomatic lumbar spinal stenosis (LSS) are challenging, and nonsurgical guidance is limited by lack of evidence.

1304. Moving to high-value care: more thoughtful use of cardiopulmonary resuscitation.

作者: Frank H Bosch.;David A Fleming.
来源: Ann Intern Med. 2015年162卷11期790-1页

1305. A cure for the high cost of hepatitis C virus treatment.

作者: Ohad Etzion.;Marc G Ghany.
来源: Ann Intern Med. 2015年162卷9期660-1页

1306. The cost-effectiveness of sofosbuvir-based regimens for treatment of hepatitis C virus genotype 2 or 3 infection.

作者: Benjamin P Linas.;Devra M Barter.;Jake R Morgan.;Mai T Pho.;Jared A Leff.;Bruce R Schackman.;C Robert Horsburgh.;Sabrina A Assoumou.;Joshua A Salomon.;Milton C Weinstein.;Kenneth A Freedberg.;Arthur Y Kim.
来源: Ann Intern Med. 2015年162卷9期619-29页
Chronic infection with hepatitis C virus (HCV) genotype 2 or 3 can be treated with sofosbuvir without interferon. Because sofosbuvir is costly, its benefits should be compared with the additional resources used.

1307. Routine iron supplementation and screening for iron deficiency anemia in pregnancy: a systematic review for the U.S. Preventive Services Task Force.

作者: Amy G Cantor.;Christina Bougatsos.;Tracy Dana.;Ian Blazina.;Marian McDonagh.
来源: Ann Intern Med. 2015年162卷8期566-76页
Routine screening and supplementation for iron deficiency anemia (IDA) in asymptomatic, nonanemic pregnant women could improve maternal and infant health outcomes.

1308. Incidental findings in the pancreas (and elsewhere): putting our patients (and ourselves) in a difficult situation.

作者: Russell P Harris.
来源: Ann Intern Med. 2015年162卷11期787-9页

1309. Screening and treating subclinical thyroid disease: getting past the impasse.

作者: Anne R Cappola.;David S Cooper.
来源: Ann Intern Med. 2015年162卷9期664-5页

1310. Screening for thyroid dysfunction: U.S. Preventive Services Task Force recommendation statement.

作者: Michael L LeFevre.; .
来源: Ann Intern Med. 2015年162卷9期641-50页
Update of the 2004 U.S. Preventive Services Task Force (USPSTF) recommendation on screening for thyroid disease.

1311. The 2015 standards for diabetes care: maintaining a patient-centered approach.

作者: Giulio R Romeo.;Martin J Abrahamson.
来源: Ann Intern Med. 2015年162卷11期785-6页

1312. ACP journal club. Dual antiplatelets for 30 mo after drug-eluting stents reduced stent thrombosis and CV and cerebrovascular events.

作者: Frederick A Spencer.;Gordon Guyatt.
来源: Ann Intern Med. 2015年162卷6期JC9页

1313. ACP journal club. Review: in diabetes with multivessel or left main CAD, PCI increases death/MI/stroke combo compared with CABG.

作者: Mark A Hlatky.
来源: Ann Intern Med. 2015年162卷6期JC8页

1314. ACP journal club. Review: ≤ 7 and > 7 days of systemic corticosteroids do not differ for efficacy in COPD exacerbations.

作者: Paul Jones.
来源: Ann Intern Med. 2015年162卷6期JC7页

1315. ACP journal club. Review: systemic corticosteroids reduce treatment failure but increase hyperglycemia in COPD exacerbations.

作者: Paul Jones.
来源: Ann Intern Med. 2015年162卷6期JC6- JC7页

1316. ACP journal club. For preventing exacerbations of COPD, withdrawal of inhaled glucocorticoids was noninferior to continuation.

作者: Matthew B Stanbrook.
来源: Ann Intern Med. 2015年162卷6期JC5页

1317. ACP journal club. Early goal-directed therapy did not reduce mortality more than usual care in early septic shock.

作者: Andrew Muck.;Bruce D Adams.
来源: Ann Intern Med. 2015年162卷6期JC4页

1318. ACP journal club. Review: β-blockers do not reduce mortality in myocardial infarction in the reperfusion era.

作者: Steven Borzak.
来源: Ann Intern Med. 2015年162卷6期JC3页

1319. ACP journal club. Review: perioperative β-blockers have variable effects on outcomes in cardiac and noncardiac surgery.

作者: Charlotte Andersson.
来源: Ann Intern Med. 2015年162卷6期JC2页

1320. ACP journal club. Dalteparin was at least as effective as UFH for VTE prevention in critically ill patients, with similar costs.

作者: Stephen M Pastores.;Maria T DeSancho.
来源: Ann Intern Med. 2015年162卷6期JC13页
共有 31424 条符合本次的查询结果, 用时 2.8346222 秒